Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07888361
Starting soon Observational

Mapping Joint Damage Patterns in Femoroacetabular Impingement

NCT07888361 · tracked via the Priya Life Science Egypt tracker
Sponsor
Assiut University
Phase
Observational
Started
2026-10
Last updated
2026-10-22

Condition(s) studied

Femoro-acetabular Impingement (FAI)

Study summary

The goal of this observational study is to document clinical outcomes after primary hip arthroscopy in patients with femoroacetabular impingement, describe the pathology zone distribution and detect whether the pathology site impact the outcomes. The main questions it aims to answer are:

* Does hip-related quality of life improve from before surgery to 12 months after surgery?
* Where inside the hip joint (front, mixed, or back) does cartilage and labral damage most commonly occur in patients undergoing arthroscopy for FAI?
* Do pain and quality-of-life outcomes at 12 months differ between patients based on the hip damage region?

Participants will

* Complete questionnaires about hip pain and function (iHOT-12, a pain scale, and a quality-of-life questionnaire) before surgery
* Undergo standard hip arthroscopy, during which the surgeon will record the exact location and grade of any joint damage found
* Complete the same questionnaires again 12 months after surgery

Eligibility

Sex
ALL
Min age
18 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * Hip pain ≥3 months with radiologically confirmed FAI morphology (cam, pincer, or combined), reproduced by the FADIR or posterior impingement test. * Failure of supervised conservative management ≥3 months. * Scheduled for elective primary hip arthroscopy. Exclusion Criteria: * Tönnis osteoarthritis grade ≥2. * Lateral centre-edge angle \<20°. * Previous ipsilateral hip surgery. * Inflammatory arthropathy. * Inability to provide written informed consent

Primary outcome measure(s)

  • Change in iHOT-12 from baseline to 12 months for the whole cohort — measured prior to and 12 months after surgery
    Participants will complete a questionnaire for the iHOT-12

Trial sites (1)

FacilityCityRegionStatus
Assiut University Trauma Hospital Asyut Asyut Governorate

More Assiut University trials in Egypt

Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder Recruiting
The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion Starting soon
Maternal Iron Deficiency and/or Iron Deficiency Anemia to Neonatal Hemoglobin Concentration and Iron Stores Starting soon
Real-Time (TRUS) Guidance in Endoscopic Treatment of BPH Starting soon
Intraoperative Lidocaine Infusion Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07888361 on ClinicalTrials.gov ↗ ← All trials in Egypt